7 results
COVID-19 Diagnosis and Management Summary

 • Clinical Presentation
 • Testing
 • Imaging
 • Laboratory Findings
 •
COVID-19 Diagnosis ... #COVID19 #diagnosis ... #management #treatment ... #summary #sarscov2 ... #coronavirus #testing
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
emergency 2020-3-12 Diagnosis ... illness) • 20-40% dyspnea ... #Cheatsheet #Diagnosis ... #Management #Summary ... #SARSCoV2 #Coronavirus
Possible Approach to Immunosuppression in Severe COVID-19

The diagnosis and treatment of cytokine storm remains unknown and
-19 The diagnosis ... and treatment of ... #management #schema ... #criticalcare #algorithm ... #SARSCOV2 #Coronavirus
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
UCSF COVID-19 Adult ... Cough 45-80%, dyspnea ... Evaluation #Guide #Diagnosis ... #Algorithm #Protocol ... #SARSCoV2 #Coronavirus
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... pneumonia, ARDS, DAH ... Dyspnea 3. ... macrophages Treatment ... #diagnosis #management
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Symptoms: Cough, dyspnea ... : Clinical diagnosis ... + path w/ organizing ... , neoplastic) TREATMENT ... #management #pulmonary
Type L:
 - Low elastance. The nearly normal compliance indicates that the amount of gas in
this stage, the pulmonary ... Citerio @Dr_Cit #COVID19 ... Phenotypes #Variations #Diagnosis ... #Management #SARSCOV2 ... #Coronavirus